We recently compiled a list of the 6 Stocks Jim Cramer Talked About This Week.In this article, we are going to take a look at where Tesla, Inc. (NASDAQ:TSLA) stands against the other stocks Jim Cramer talked about this week.
Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with cult stocks, which in hindsight appear to be clear success stories. He discussed how, sometimes, the fundamentals that guide traditional investing can hold investors back from seizing these opportunities.
Cramer acknowledged that many investors, himself included, have missed out on these types of stocks and emphasized that it’s important to examine why these opportunities were missed to avoid making the same mistake again. He mentioned that, early on, he and others mistakenly believed that fundamentals were always the key to making sound investments, only to realize that in certain situations, that’s not the case.
Cramer highlighted that in the case of cult stocks, the stock price can sometimes move independently of the company’s underlying performance. These stocks can experience long-term growth due to a fiercely loyal shareholder base, and as a result, they may not follow traditional market behavior. He explained that while meme stocks might follow similar trends, cult stocks have staying power and can defy expectations.
“There’s a lesson here and it is a brutal one. Sometimes conventional methods of valuation are completely worthless, and you need to embrace the dynamics of cult stocks. The trick is to recognize when we’re in one of those moments. In 2025, let’s strive to find the stocks of companies that do defy orthodoxy.”
Shifting the focus to the healthcare sector, Cramer noted that although the market has seen significant gains in recent weeks, it has become increasingly difficult to find promising investment opportunities. However, he believes that healthcare could be the place to look as 2025 approaches. Cramer explained that healthcare stocks have significantly underperformed this year, trailing behind the broader market, which has created an opportunity.
“Now, it's hard to bet on healthcare when the Fed's cutting rates because these are textbook slowdown stocks and thrived when the economy was not doing so hot, but the election was also a clear negative catalyst for the group.”
He noted that President-elect Trump’s potential appointment of Robert F. Kennedy Jr. to head the Department of Health and Human Services is a major concern for the industry, especially given Kennedy’s reputation as a vaccine skeptic. Cramer also warned that if the second Trump administration attempts to dismantle Obamacare, it could lead to many Americans losing access to affordable health insurance, which would add further risk to healthcare stocks.
Despite these concerns, Cramer believes that, at some point, all the negative factors will be factored into healthcare stocks, and that moment is fast approaching. He stated that the damage done to healthcare stocks, particularly in biotech and pharmaceuticals, has been severe, but he sees an opportunity as these stocks have become too cheap relative to their long-term potential.
“With so many groups hitting new highs, I think it's worth taking a step back and putting money to work in one of the most hated groups out there, healthcare. These stocks have simply gotten too cheap given its prospects, especially Eli Lilly, Vertex Pharma, and Bristol-Myers.”
Our Methodology
For this article, we compiled a list of 6 stocks that were discussed by Jim Cramer during the recent episode of Mad Money on December 16. We listed the stocks in ascending order of their hedge fund sentiment as of the third quarter, which was taken from Insider Monkey’s database of 900 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
Cramer on Tesla, Inc. (TSLA): It's More About the Ethos Than the Cars
Discussing cult stocks, Cramer talked about Tesla, Inc. (NASDAQ:TSLA) and said:
“This rally since the election is one for the ages. It's a movement, in retrospect, everyone should have seen coming, right? I mean, why not? Elon Musk has been all in with the winner of the presidential election. Their electric cars are doing much better than everyone else's. Full self-driving could be around the corner. But now let's look at what might have kept you out of the stock. If you go back in time to when we found out that Elon was a big-time Trump supporter, the media was filled with how long will that last chatter. The president-elect is famously mercurial while Elon Musk is obviously brilliant but equally arbitrary and capricious. The idea that these two could bond in any way before they clash seemed inevitable.
Tesla (NASDAQ:TSLA) stock has risen significantly after the U.S. presidential election, driven by strong financial growth and CEO Elon Musk's relationship with President-Elect Trump. This was boosted by Musk's appointment to a government efficiency role and reports that Trump’s team would focus on self-driving vehicle regulations. Tesla also made strides in autonomy with the release of version 13 of its Full Self-Driving software, moving closer to fully autonomous vehicles.
On December 16, Mizuho analyst Vijay Rakesh raised the stock’s rating to Outperform from Neutral, increasing the price target to $515 from $230. The firm believes Tesla’s autonomy software is advancing towards widespread commercialization and sees a more flexible regulatory environment as favorable for the autonomous sector’s growth. Additionally, the firm suggests that new policies under the Trump administration, such as the repeal of consumer EV tax credits, will benefit Tesla by providing a more competitive EV cost structure compared to its peers.
Gene Munster, managing partner at Deepwater Asset Management, mentioned in an interview with Business Insider that autonomous vehicles in Western markets are likely to be driven by only a few companies, with Tesla (NASDAQ:TSLA) being one of the primary players. According to Munster, one of its key advantages in this race is its ability to scale autonomous services, given that millions of Tesla cars are already on the road.
He highlighted that the company’s data collection capabilities, which are crucial to the development of autonomous technology, are likely to outpace any hardware disadvantages Tesla may face. Anthony Levandowski, who co-founded Google's self-driving car program, known as Waymo, also expressed confidence in Tesla's autonomous vehicle potential, stating that the company is in a stronger position than Waymo.
Tesla's large fleet of semi-autonomous vehicles, continuously collects data to improve technology. Levandowski believes Tesla's vast data advantage, with millions of vehicles feeding real-time information, will be a key differentiator, potentially gathering 10,000 to 1 million times more data than Waymo across various driving scenarios.
Overall TSLA ranks 3rd on our list of the stocks Jim Cramer talked about this week. While we acknowledge the potential of TSLA as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TSLA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
